NVO, LLY: Looking For Winners In The Pharma Space

<p>Novo Nordisk (NVO) has a notable new trial that starts this week, says Michael Nedelcovych. He discusses how Cowen has a buy rating on NVO. He also talks about NVO's earnings which were released November 2nd. He then goes over how to look for winners in the pharma space, highlighting Eli Lilly and Company (LLY). tune in to find out more about the stock market today.</p>